These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38035181)

  • 21. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
    Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conventional Karyotyping and Fluorescence
    Crabtree M; Cai J; Qing X
    J Hematol; 2022 Jun; 11(3):87-91. PubMed ID: 35837374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of chromosomal abnormalities detected by interphase fluorescence in situ hybridization in newly diagnosed multiple myeloma patients.
    Hu Y; Chen L; Sun CY; She XM; Ai LS; Qin Y
    Chin Med J (Engl); 2011 Oct; 124(19):2981-5. PubMed ID: 22040539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.
    Kadam Amare PS; Jain H; Nikalje S; Sengar M; Menon H; Inamdar N; Subramanian PG; Gujral S; Shet T; Epari S; Nair R
    Indian J Med Res; 2016 Oct; 144(4):536-543. PubMed ID: 28256461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment.
    Pozdnyakova O; Crowley-Larsen P; Zota V; Wang SA; Miron PM
    Cancer Genet Cytogenet; 2009 Mar; 189(2):112-7. PubMed ID: 19215792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement.
    Kim S; Kim H; Kang H; Kim J; Eom H; Kim T; Yoon SS; Suh C; Lee D;
    J Hematol Oncol; 2013 Oct; 6():76. PubMed ID: 24220305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
    Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
    J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma.
    Ha J; Cho H; Lee TG; Shin S; Chung H; Jang JE; Kim SJ; Cheong JW; Lee ST; Kim JS; Choi JR
    Sci Rep; 2022 May; 12(1):8287. PubMed ID: 35585097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A diagnostic approach to detect cytogenetic heterogeneity and its prognostic significance in multiple myeloma.
    Kalal AA; Arumugam M; Shetty VV; Shetty KP; Krishna R; Shetty RA; Kulkarni NV; Shetty DP
    J Taibah Univ Med Sci; 2023 Oct; 18(5):1138-1147. PubMed ID: 37206191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detecting chromosomal aberrations in myelodysplastic syndrome with fluorescence in situ hybridization and conventional cytogenetic analysis].
    Cao P; Li Y; Li X; Zhang G; Chen F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 39(6):605-11. PubMed ID: 25011965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal heterogeneity by fluorescence in situ hybridization in multiple myeloma: enhanced cytogenetic risk stratification.
    Abdel-Qader HY; Fouad DA; Abuelela SA; Ismail HMA; Boshnaq NH
    Egypt J Med Hum Genet; 2022; 23(1):66. PubMed ID: 37521829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India.
    Govindasamy P; Pandurangan P; Tarigopula A; Mani R; R Samuel C
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):235-241. PubMed ID: 30678438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
    Wu KL; Beverloo B; Velthuizen SJ; Sonneveld P
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
    Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interphase fluorescence in situ hybridization on selected plasma cells is superior in the detection of cytogenetic aberrations in plasma cell dyscrasia.
    Put N; Lemmens H; Wlodarska I; Konings P; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L
    Genes Chromosomes Cancer; 2010 Nov; 49(11):991-7. PubMed ID: 20662075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients.
    Jian Y; Chen X; Zhou H; Zhu W; Liu N; Geng C; Chen W
    Medicine (Baltimore); 2016 May; 95(19):e3521. PubMed ID: 27175647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis.
    Dewald GW; Kyle RA; Hicks GA; Greipp PR
    Blood; 1985 Aug; 66(2):380-90. PubMed ID: 3926026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics and Prognostic Significance of Cytogenetic Abnormalities in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement].
    Liu W; Lyu R; Huang WY; Li CW; Liu H; Li J; Zou DH; Qiu LG; Yi SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):761-765. PubMed ID: 28641631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.